Concepedia

Ryo Wakejima

RW

Statistics

Publications

6

Citations

181

H-Index

6

Active since

2019

Affiliations

Tokyo Medical and Dental University(Current)

The Cancer Institute Hospital

Japanese Foundation For Cancer Research

International University of Health and Welfare

Ryo Wakejima is an author at Tokyo Medical and Dental University specializing in oncology, medicine, and pathology.

ORCID

Publications per year

2019–2023

6

Publications

6

Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56

Rie Sakakibara, Maki Kobayashi, Naoko Takahashi et al. · The American Journal of Surgical Pathology · 2020 · 78 citations

, , +17

Postoperative Atrial Fibrillation in Lung Cancer Lobectomy—Analysis of Risk Factors and Prognosis

Hironori Ishibashi, Ryo Wakejima, Ayaka Asakawa et al. · World Journal of Surgery · 2020 · 41 citations

, , +16

Postoperative Delirium in Lung Cancer Anatomical Resection—Analysis of Risk Factors and Prognosis

Hironori Ishibashi, Ryo Wakejima, Ayaka Asakawa et al. · World Journal of Surgery · 2022 · 19 citations

, , +14

Mucinous lung adenocarcinoma, particularly referring to <i>EGFR</i>‐mutated mucinous adenocarcinoma

Ryo Wakejima, Kentaro Inamura, Hironori Ninomiya et al. · Pathology International · 2019 · 16 citations

, , +17

Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma

Masanori Matsuda, Hironori Ninomiya, Ryo Wakejima et al. · Pathology - Research and Practice · 2020 · 16 citations

, , +11

1–5 of 6